Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4, 2020
Anika Therapeutics (NASDAQ: ANIK) plans to release its third quarter 2020 financial results after market close on November 4, 2020. The company will also host an investor conference call on the same day at 5:00 PM ET to discuss the financial results and business highlights. Investors can participate by dialing in or accessing a live audio webcast via Anika's Investor Relations page.
Founded to advance orthopedic care, Anika specializes in joint preservation and minimally invasive products to aid in osteoarthritis pain management and other related areas.
- Scheduled third quarter 2020 earnings release and conference call may drive investor interest.
- Focus on early intervention in orthopedics highlights growth potential in a high-demand market.
- None.
BEDFORD, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care, today announced that the Company plans to issue its third quarter 2020 financial results after the close of the market on Wednesday, November 4, 2020 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.
The conference call can be accessed by dialing 1-855-327-6837 (toll-free domestic) or 1-631-891-4304 (international) and providing the conference ID number 10011177. A live audio webcast will be available in the "Investor Relations" section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. For more information, please visit www.anika.com.
| For Investor Inquiries: Anika Therapeutics, Inc. Kristen Galfetti, 781-457-9000 Executive Director, Investor Relations investorrelations@anika.com | For Media Inquiries: W2O Group Rachel Girard, 617-379-6760 rgirard@w2ogroup.com |
FAQ
When will Anika Therapeutics announce its third quarter 2020 financial results?
What time is the Anika Therapeutics investor conference call?
How can I access the Anika Therapeutics conference call?
Where can I find the financial results and presentations from Anika Therapeutics?
